Critical	O
cytoplasmic	B-protein
domains	I-protein
of	O
human	B-protein
interleukin-9	I-protein
receptor	I-protein
alpha	I-protein
chain	I-protein
in	O
interleukin	B-protein
-9-mediated	O
cell	O
proliferation	O
and	O
signal	O
transduction	O
.	O

Interleukin-9	B-protein
receptor	I-protein
(	I-protein
IL-9R	I-protein
)	I-protein
complex	I-protein
consists	O
of	O
a	O
ligand-specific	B-protein
alpha	I-protein
chain	I-protein
and	O
IL-2R	B-protein
gamma	I-protein
chain	I-protein
.	O

In	O
this	O
study	O
,	O
two	O
regions	O
in	O
the	O
cytoplasmic	B-protein
domain	I-protein
of	O
human	B-protein
IL-9Ralpha	I-protein
were	O
found	O
to	O
be	O
important	O
for	O
IL-9	B-protein
-mediated	O
cell	O
growth	O
.	O

A	O
membrane-proximal	B-protein
region	I-protein
that	O
contains	O
the	O
BOX1	B-protein
consensus	I-protein
sequence	I-protein
is	O
required	O
for	O
IL-9	B-protein
-induced	O
cell	O
proliferation	O
and	O
tyrosine	O
phosphorylation	O
of	O
Janus	B-protein
kinases	I-protein
(	O
JAKs	B-protein
)	O
.	O

Deletion	O
of	O
this	O
region	O
or	O
internal	O
deletion	O
of	O
the	O
BOX1	B-protein
motif	I-protein
abrogated	O
IL-9	B-protein
-induced	O
cell	O
proliferation	O
and	O
signal	O
transduction	O
.	O

However	O
,	O
substitution	O
of	O
the	O
Pro-X-Pro	B-protein
in	O
the	O
BOX1	B-protein
motif	I-protein
with	O
Ala-X-Ala	B-protein
failed	O
to	O
abolish	O
IL-9	B-protein
-induced	O
cell	O
proliferation	O
but	O
decreased	O
IL-9	B-protein
-mediated	O
tyrosine	O
phosphorylation	O
of	O
JAK	B-protein
kinases	I-protein
,	O
insulin	B-protein
receptor	I-protein
substrate-2	I-protein
,	O
and	O
signal	B-protein
transducer	I-protein
and	I-protein
activator	I-protein
of	I-protein
transcription	I-protein
3	I-protein
(	O
STAT3	B-protein
)	O
and	O
expression	O
of	O
c-myc	B-DNA
and	O
junB	B-DNA
.	O

Another	O
important	O
region	O
is	O
downstream	O
of	O
the	O
BOX1	B-protein
motif	I-protein
and	O
contains	O
a	O
STAT3	B-DNA
binding	I-DNA
motif	I-DNA
YLPQ	B-DNA
.	O

Deletion	O
of	O
this	O
region	O
significantly	O
impaired	O
IL-9	B-protein
-induced	O
cell	O
growth	O
,	O
activation	O
of	O
JAK	B-protein
kinases	I-protein
,	O
insulin	B-protein
receptor	I-protein
substrate-2	I-protein
,	O
and	O
STAT3	B-protein
and	O
expression	O
of	O
early	B-DNA
response	I-DNA
genes	I-DNA
.	O

A	O
point	O
mutation	O
changing	O
YLPQ	B-DNA
into	O
YLPA	B-DNA
greatly	O
reduced	O
IL-9	B-protein
-induced	O
activation	O
of	O
STAT3	B-protein
and	O
expression	O
of	O
c-myc	B-DNA
but	O
did	O
not	O
affect	O
cell	O
proliferation	O
.	O

These	O
results	O
suggest	O
that	O
cooperation	O
or	O
cross-talk	O
of	O
signaling	O
molecules	O
associated	O
with	O
different	O
domains	O
of	O
IL-9Ralpha	B-protein
other	O
than	O
STAT3	B-protein
is	O
essential	O
for	O
IL-9	B-protein
-mediated	O
cell	O
growth	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

34	NULL
,	NULL
Issue	NULL
of	NULL
August	NULL
22	NULL
,	NULL
pp	NULL
.	NULL

21334-23140	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Critical	NULL
Cytoplasmic	NULL
Domains	NULL
of	NULL
Human	NULL
Interleukin-9	NULL
Receptor	NULL
a	NULL
Chain	NULL
in	NULL
Interleukin-9-mediated	NULL
Cell	NULL
Proliferation	NULL
and	NULL
Signal	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
9	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
June	NULL
13	NULL
,	NULL
1997	NULL
)	NULL
Yuan	NULL
Xiao	NULL
Zhu	NULL
$	NULL
§	NULL
,	NULL
Hui	NULL
Bin	NULL
Sun	NULL
#	NULL
§	NULL
,	NULL
Monica	NULL
Lik-Shing	NULL
Tsang1	NULL
,	NULL
Jon	NULL
McMahel	NULL
#	NULL
,	NULL
Susan	NULL
Grigsby	NULL
$	NULL
,	NULL
Tinggui	NULL
Yin	NULL
#	NULL
§	NULL
,	NULL
and	NULL
Yu-Chung	NULL
Yang	NULL
#	NULL
§|**	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
{	NULL
Medicine	NULL
(	NULL
Hematology	NULL
/Oncology	NULL
)	NULL
and	NULL
||Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Indiana	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
and	NULL
the	NULL
§Walther	NULL
Cancer	NULL
Institute	NULL
,	NULL
Indianapolis	NULL
,	NULL
Indiana	NULL
46202	NULL
and	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
Minnesota	NULL
55413-2647	NULL
Interleukin-9	NULL
receptor	NULL
(	NULL
IL-9R	NULL
)	NULL
complex	NULL
consists	NULL
of	NULL
a	NULL
ligand-specific	NULL
«	NULL
chain	NULL
and	NULL
IL-2R	NULL
y	NULL
chain	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
two	NULL
regions	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
human	NULL
IL-I9Ra	NULL
«	NULL
were	NULL
found	NULL
to	NULL
be	NULL
important	NULL
for	NULL
IL-9-mediated	NULL
cell	NULL
growth	NULL
.	NULL

A	NULL
membrane-proximal	NULL
region	NULL
that	NULL
contains	NULL
the	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
is	NULL
required	NULL
for	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Janus	NULL
kinases	NULL
(	NULL
JAKs	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
this	NULL
region	NULL
or	NULL
internal	NULL
deletion	NULL
of	NULL
the	NULL
BOX1	NULL
motif	NULL
abrogated	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
and	NULL
signal	NULL
transduction	NULL
.	NULL

However	NULL
,	NULL
substitution	NULL
of	NULL
the	NULL
Pro-X-Pro	NULL
in	NULL
the	NULL
BOX1	NULL
motif	NULL
with	NULL
Ala-X-Ala	NULL
failed	NULL
to	NULL
abolish	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
but	NULL
decreased	NULL
IL-9-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
,	NULL
insulin	NULL
receptor	NULL
substrate-2	NULL
,	NULL
and	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
3	NULL
(	NULL
STAT3	NULL
)	NULL
and	NULL
expression	NULL
of	NULL
ec-mye	NULL
and	NULL
junB	NULL
.	NULL

Another	NULL
important	NULL
region	NULL
is	NULL
downstream	NULL
of	NULL
the	NULL
BOX1	NULL
motif	NULL
and	NULL
contains	NULL
a	NULL
STAT3	NULL
binding	NULL
motif	NULL
YLPQ	NULL
.	NULL

Deletion	NULL
of	NULL
this	NULL
region	NULL
significantly	NULL
impaired	NULL
IL-9-induced	NULL
cell	NULL
growth	NULL
,	NULL
activation	NULL
of	NULL
JAK	NULL
kinases	NULL
,	NULL
insulin	NULL
receptor	NULL
substrate-2	NULL
,	NULL
and	NULL
STAT3	NULL
and	NULL
expression	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
.	NULL

A	NULL
point	NULL
mutation	NULL
changing	NULL
YLPQ	NULL
into	NULL
YLPA	NULL
greatly	NULL
reduced	NULL
IL-9-induced	NULL
activation	NULL
of	NULL
STAT3	NULL
and	NULL
expression	NULL
of	NULL
ec-mye	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
cell	NULL
proliferation	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
cooperation	NULL
or	NULL
cross-talk	NULL
of	NULL
signaling	NULL
molecules	NULL
associated	NULL
with	NULL
different	NULL
domains	NULL
of	NULL
IL-I9Ra	NULL
«	NULL
other	NULL
than	NULL
STAT3	NULL
is	NULL
essential	NULL
for	NULL
IL-9-mediated	NULL
cell	NULL
growth	NULL
.	NULL

Interleukin	NULL
9	NULL
(	NULL
IL-9	NULL
)	NULL
is	NULL
a	NULL
T	NULL
cell-derived	NULL
multifunctional	NULL
growth	NULL
factor	NULL
that	NULL
exerts	NULL
its	NULL
effects	NULL
on	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
and	NULL
hematopoietic	NULL
progenitors	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
biological	NULL
functions	NULL
of	NULL
IL-9	NULL
include	NULL
its	NULL
ability	NULL
to	NULL
stimulate	NULL
proliferation	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
to	NULL
enhance	NULL
production	NULL
of	NULL
immu-noglobulin	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
to	NULL
promote	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
mast	NULL
cells	NULL
and	NULL
hematopoietic	NULL
progenitors	NULL
(	NULL
3-7	NULL
)	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
IL-9	NULL
in	NULL
lymphomagenesis	NULL
has	NULL
been	NULL
suggested	NULL
by	NULL
in	NULL
vivo	NULL
studies	NULL
(	NULL
8	NULL
)	NULL
in	NULL
which	NULL
a	NULL
higher	NULL
susceptibility	NULL
to	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
RO1HL48819	NULL
and	NULL
RO1DK	NULL
50570	NULL
(	NULL
to	NULL
Y.-C	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertise-ment	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
817-274-7512	NULL
;	NULL
Fax	NULL
:	NULL
817-274-7592	NULL
;	NULL
E-mail	NULL
:	NULL
yu-chung	NULL
.	NULL

yang	NULL
@	NULL
iuce.iupui.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
R	NULL
,	NULL
receptor	NULL
;	NULL
h	NULL
,	NULL
human	NULL
;	NULL
m	NULL
,	NULL
murine	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
;	NULL
IRS-2	NULL
,	NULL
insulin	NULL
receptor	NULL
substrate-2	NULL
;	NULL
SIE	NULL
,	NULL
c-sis-induci-ble	NULL
element	NULL
;	NULL
APRF	NULL
,	NULL
acute-phase	NULL
response	NULL
factor	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovi-rus	NULL
;	NULL
PVDF	NULL
,	NULL
polyvinylidene	NULL
difluoride	NULL
.	NULL

21334	NULL
T	NULL
cell	NULL
lymphoma	NULL
was	NULL
observed	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
IL-9	NULL
constitutively	NULL
and	NULL
by	NULL
in	NULL
vitro	NULL
experiments	NULL
(	NULL
9	NULL
)	NULL
in	NULL
which	NULL
IL-9	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
protect	NULL
mouse	NULL
lymphoma	NULL
cells	NULL
from	NULL
dexamethasone-induced	NULL
apoptosis	NULL
.	NULL

The	NULL
functions	NULL
of	NULL
IL-9	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
IL-9	NULL
receptor	NULL
(	NULL
IL-9R	NULL
)	NULL
,	NULL
which	NULL
consists	NULL
of	NULL
a	NULL
ligand-specific	NULL
a	NULL
chain	NULL
and	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
y	NULL
chain	NULL
.	NULL

IL-2R	NULL
y	NULL
chain	NULL
,	NULL
normally	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
common	NULL
y	NULL
chain	NULL
(	NULL
7	NULL
,	NULL
chain	NULL
)	NULL
,	NULL
is	NULL
shared	NULL
by	NULL
receptors	NULL
for	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-9	NULL
,	NULL
and	NULL
IL-15	NULL
(	NULL
10-13	NULL
)	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
signaling	NULL
pathways	NULL
elicited	NULL
by	NULL
these	NULL
cy-tokines	NULL
are	NULL
quite	NULL
similar	NULL
,	NULL
which	NULL
probably	NULL
explains	NULL
in	NULL
part	NULL
the	NULL
functional	NULL
redundancy	NULL
of	NULL
these	NULL
cytokines	NULL
.	NULL

IL-9R	NULL
a	NULL
chain	NULL
(	NULL
IL-9Ra	NULL
)	NULL
is	NULL
IL-9-specific	NULL
and	NULL
is	NULL
responsible	NULL
for	NULL
IL-9	NULL
binding	NULL
.	NULL

The	NULL
cDNAs	NULL
encoding	NULL
mouse	NULL
and	NULL
human	NULL
IL-9Ra	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
14-15	NULL
)	NULL
.	NULL

IL-9Ra	NULL
belongs	NULL
to	NULL
the	NULL
hematopoietic	NULL
receptor	NULL
superfamily	NULL
and	NULL
has	NULL
no	NULL
intrinsic	NULL
tyrosine	NULL
kinase	NULL
motif	NULL
in	NULL
its	NULL
cytoplasmic	NULL
region	NULL
.	NULL

Several	NULL
homologous	NULL
sequences	NULL
,	NULL
such	NULL
as	NULL
the	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
and	NULL
a	NULL
serine-rich	NULL
region	NULL
,	NULL
which	NULL
were	NULL
demonstrated	NULL
to	NULL
be	NULL
important	NULL
for	NULL
IL-2R	NULL
$	NULL
function	NULL
(	NULL
16	NULL
)	NULL
,	NULL
are	NULL
also	NULL
present	NULL
in	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
human	NULL
IL-9Ra	NULL
(	NULL
hIL-9Ra	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
several	NULL
biochemical	NULL
events	NULL
including	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
,	NULL
activation	NULL
of	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
proteins	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
nuclear	NULL
proto-oncogenes	NULL
are	NULL
involved	NULL
in	NULL
IL-9-mediated	NULL
signal	NULL
transduction	NULL
(	NULL
17-19	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletions	NULL
and	NULL
point	NULL
mutations	NULL
were	NULL
made	NULL
in	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
hIL-9Ra	NULL
.	NULL

These	NULL
mutants	NULL
were	NULL
transfected	NULL
into	NULL
a	NULL
mouse	NULL
IL-9-dependent	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
TS1	NULL
,	NULL
to	NULL
investigate	NULL
the	NULL
functions	NULL
of	NULL
different	NULL
domains	NULL
of	NULL
hIL-9Ra	NULL
in	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
and	NULL
activation	NULL
of	NULL
JAK/STAT	NULL
and	NULL
primary	NULL
response	NULL
genes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
Construction-The	NULL
full-length	NULL
cDNA	NULL
for	NULL
hIL-9Ra	NULL
«	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
Ming-Shi	NULL
Chang	NULL
at	NULL
Amgen	NULL
(	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
hIL-9Ra	NULL
cDNA	NULL
fragments	NULL
containing	NULL
different	NULL
C-terminal	NULL
truncations	NULL
of	NULL
the	NULL
cytoplasmic	NULL
region	NULL
were	NULL
generated	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

The	NULL
full-length	NULL
and	NULL
C-terminal-truncated	NULL
cDNAs	NULL
for	NULL
hIL-9Ra	NULL
were	NULL
subcloned	NULL
into	NULL
blunt-ended	NULL
Xbal	NULL
site	NULL
in	NULL
pRe/CMV	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

Site-directed	NULL
mutations	NULL
in	NULL
the	NULL
BOX1	NULL
and	NULL
STAT3	NULL
binding	NULL
motifs	NULL
(	NULL
BOXm	NULL
and	NULL
STAT3	NULL
m	NULL
)	NULL
within	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
hIL-9Ra	NULL
were	NULL
generated	NULL
using	NULL
the	NULL
Altered	NULL
Sites	NULL
II	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
systems	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Internal	NULL
deletion	NULL
of	NULL
the	NULL
BOX1L	NULL
motif	NULL
(	NULL
between	NULL
amino	NULL
acids	NULL
298	NULL
and	NULL
815	NULL
)	NULL
in	NULL
hIL-9Ra	NULL
(	NULL
BOXd	NULL
)	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
method	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

To	NULL
construct	NULL
pFlagIL-9R	NULL
plasmids	NULL
,	NULL
an	NULL
NdeI-Xbal	NULL
restricted	NULL
fragment	NULL
from	NULL
pFlag-CMV-1	NULL
expression	NULL
vector	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
)	NULL
that	NULL
contained	NULL
part	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
and	NULL
the	NULL
coding	NULL
sequence	NULL
for	NULL
preprotrypsin	NULL
leader	NULL
peptide	NULL
and	NULL
flag	NULL
epitope	NULL
tag	NULL
was	NULL
subcloned	NULL
into	NULL
various	NULL
pRe/CMV-IL-9R	NULL
constructs	NULL
to	NULL
replace	NULL
Ndel-Xbal-restricted	NULL
DNA	NULL
fragments	NULL
.	NULL

The	NULL
resulting	NULL
plasmids	NULL
were	NULL
designated	NULL
as	NULL
pFlagIL-9R	NULL
W	NULL
,	NULL
pFlagIL-9R	NULL
D1	NULL
,	NULL
pFlagIL-9R	NULL
D2	NULL
,	NULL
pFlagIL-9R	NULL
D3	NULL
,	NULL
pFlagIL-9R	NULL
D4	NULL
,	NULL
pFlagIL-9R	NULL
BOXm	NULL
,	NULL
pFlagIL-9R	NULL
STAT3	NULL
m	NULL
,	NULL
and	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
IL-9	NULL
Receptor	NULL
a	NULL
Domains	NULL
Critical	NULL
for	NULL
Signal	NULL
Transduction	NULL
21335	NULL
Feo	NULL
TM	NULL
_	NULL
BOX1	NULL
SR	NULL
IL-9R	NULL
ox	NULL
%	NULL
w	NULL
22	NULL
w	NULL
[	NULL
,	NULL
\	NULL
,	NULL
\|	NULL
%	NULL
aas	NULL
D1	NULL
C	NULL
--	NULL
E-I	NULL
_BPH	NULL
]	NULL
aa460	NULL
D2	NULL
[	NULL
F	NULL
1	NULL
aad22	NULL
pRe/CMV	NULL
D3	NULL
C	NULL
ET	NULL
IAA	NULL
]	NULL
aa338	NULL
BGH	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
D4	NULL
aa295	NULL
-_	NULL
CMV	NULL
BOXd	NULL
I	NULL
%	NULL
I	NULL
BOXm	NULL
(	NULL
PXP	NULL
-	NULL
>	NULL
AXA	NULL
)	NULL
som	NULL
|	NULL
rt	NULL
--	NULL
p	NULL
1	NULL
TAT3m	NULL
(	NULL
YLPQ	NULL
-	NULL
>	NULL
YLPA	NULL
)	NULL
STAT3m	NULL
[	NULL
[	NULL
j	NULL
7	NULL
l	NULL
%	NULL
I	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
diagram	NULL
of	NULL
wild-type	NULL
,	NULL
C-terminal	NULL
truncations	NULL
,	NULL
internal	NULL
deletion	NULL
,	NULL
and	NULL
point	NULL
mutations	NULL
of	NULL
hIL-9Ra	NULL
.	NULL

The	NULL
construction	NULL
of	NULL
pFlagIL-9R	NULL
plasmids	NULL
containing	NULL
wild-type	NULL
(	NULL
W	NULL
)	NULL
and	NULL
mutated	NULL
hIL-9Ra	NULL
was	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Flag	NULL
peptide	NULL
,	NULL
transmem-brane	NULL
domain	NULL
(	NULL
TM	NULL
)	NULL
,	NULL
BOX1	NULL
motif	NULL
(	NULL
BOX1	NULL
)	NULL
,	NULL
serine-rich	NULL
region	NULL
(	NULL
SR	NULL
)	NULL
,	NULL
and	NULL
point	NULL
mutation	NULL
within	NULL
BOX1	NULL
motif	NULL
(	NULL
BOXm	NULL
)	NULL
or	NULL
STAT3	NULL
binding	NULL
site	NULL
(	NULL
STAT3	NULL
m	NULL
)	NULL
are	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
numbers	NULL
given	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
each	NULL
protein	NULL
represent	NULL
relevant	NULL
positions	NULL
of	NULL
amino	NULL
acids	NULL
at	NULL
the	NULL
truncated	NULL
end	NULL
(	NULL
according	NULL
to	NULL
the	NULL
numbering	NULL
system	NULL
in	NULL
published	NULL
hIL-9	NULL
cDNA	NULL
sequence	NULL
;	NULL
Ref	NULL
.	NULL

14	NULL
)	NULL
.	NULL

CMV	NULL
and	NULL
bovine	NULL
growth	NULL
hormone	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
represent	NULL
CMV	NULL
promoter	NULL
and	NULL
polyadenylation	NULL
signal	NULL
from	NULL
bovine	NULL
growth	NULL
hormone	NULL
present	NULL
in	NULL
the	NULL
vector	NULL
.	NULL

aa	NULL
,	NULL
amino	NULL
acid	NULL
(	NULL
s	NULL
)	NULL
.	NULL

pFlagIL-9R	NULL
BOXd	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

All	NULL
plasmid	NULL
constructs	NULL
were	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Cell	NULL
Cultures	NULL
and	NULL
Transfection-Murine	NULL
T	NULL
cell	NULL
clone	NULL
,	NULL
TS1	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
Click	NULL
's	NULL
medium	NULL
(	NULL
Irvine	NULL
Scientific	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
1	NULL
ng/ml	NULL
mIL-9	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
.	NULL

For	NULL
stable	NULL
expression	NULL
of	NULL
hIL-9Ra	NULL
,	NULL
TS1	NULL
cells	NULL
in	NULL
exponential	NULL
growth	NULL
phase	NULL
were	NULL
suspended	NULL
at	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells/ml	NULL
in	NULL
culture	NULL
medium	NULL
.	NULL

0.3	NULL
ml	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
transferred	NULL
into	NULL
a	NULL
0.4-cm	NULL
cuvette	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
pFlagIL-9R	NULL
DNAs	NULL
.	NULL

Following	NULL
a	NULL
single	NULL
250-V/960-microfarad	NULL
pulse	NULL
with	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
,	NULL
each	NULL
sample	NULL
was	NULL
cultured	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
medium	NULL
with	NULL
mIL-9	NULL
(	NULL
1	NULL
ng/m	NULL
!	NULL
)	NULL

at	NULL
87	NULL
°C	NULL
.	NULL

Stable	NULL
transfectants	NULL
were	NULL
isolated	NULL
by	NULL
selection	NULL
in	NULL
1	NULL
mg/ml	NULL
G418	NULL
for	NULL
3	NULL
weeks	NULL
.	NULL

Cells	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
FlagIL-9R	NULL
proteins	NULL
were	NULL
further	NULL
enriched	NULL
by	NULL
Fluorescence-activated	NULL
Cell	NULL
Sorter	NULL
using	NULL
an	NULL
anti-Flag	NULL
M2	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Kodak	NULL
)	NULL
and	NULL
goat	NULL
anti-mouse	NULL
IgG1-fluorescein	NULL
isothiocyanate	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Proliferation	NULL
Assay-Transfectants	NULL
expressing	NULL
different	NULL
forms	NULL
of	NULL
hIL-9Ra	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
,	NULL
seeded	NULL
in	NULL
triplicates	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/200	NULL
ul	NULL
of	NULL
culture	NULL
medium/well	NULL
either	NULL
without	NULL
growth	NULL
factors	NULL
or	NULL
supplemented	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
hIL-9	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
8	NULL
days	NULL
,	NULL
1	NULL
uCi	NULL
of	NULL
[	NULL
°HJthymidine	NULL
(	NULL
Amersham	NULL
Life	NULL
Science	NULL
,	NULL
Inc.	NULL
,	NULL
specific	NULL
activity	NULL
5	NULL
Ci/mmol	NULL
)	NULL
was	NULL
added	NULL
per	NULL
well	NULL
and	NULL
further	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
87°C	NULL
before	NULL
harvest	NULL
.	NULL

The	NULL
incorporated	NULL
[	NULL
*HIthymidine	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
(	NULL
Beckman	NULL
Instruments	NULL
,	NULL
LS	NULL
60001C	NULL
)	NULL
.	NULL

Western	NULL
Blots	NULL
and	NULL
Immunoprecipitation-Cells	NULL
were	NULL
starved	NULL
and	NULL
stimulated	NULL
with	NULL
hIL-9	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
about	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
8	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hIL-9	NULL
and	NULL
serum	NULL
,	NULL
then	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
stimulated	NULL
without	NULL
or	NULL
with	NULL
hIL-9	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
5	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
containing	NULL
different	NULL
proteinase	NULL
inhibitors	NULL
(	NULL
21	NULL
)	NULL
.	NULL

After	NULL
cen-trifugation	NULL
,	NULL
clear	NULL
cell	NULL
lysates	NULL
were	NULL
obtained	NULL
and	NULL
incubated	NULL
with	NULL
anti-JAK1	NULL
,	NULL
anti-JAK8	NULL
,	NULL
anti-IRS2	NULL
,	NULL
or	NULL
anti-STAT3	NULL
antibody	NULL
(	NULL
Upstate	NULL
Biotech-nology	NULL
,	NULL
Inc.	NULL
)	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Then	NULL
protein	NULL
A-agarose	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
rotated	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
separated	NULL
by	NULL
7.5	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
(	NULL
PVDF	NULL
)	NULL
membranes	NULL
and	NULL
immunoblotted	NULL
sequentially	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
Upstate	NULL
)	NULL
,	NULL
anti-JAK1	NULL
,	NULL
anti-JAK3	NULL
,	NULL
anti-IRS-2	NULL
,	NULL
and	NULL
anti-STAT3	NULL
antibodies	NULL
and	NULL
finally	NULL
detected	NULL
with	NULL
the	NULL
ECL	NULL
techniques	NULL
according	NULL
to	NULL
manufacturer	NULL
instructions	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
FlagIL-9R	NULL
expression	NULL
,	NULL
total	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
from	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
anti-Flag	NULL
M2	NULL
antibody	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-hIL-9R	NULL
antibody	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
primary	NULL
response	NULL
gene	NULL
expression	NULL
,	NULL
transfectants	NULL
expressing	NULL
different	NULL
mutant	NULL
forms	NULL
of	NULL
hIL-9Re	NULL
were	NULL
starved	NULL
and	NULL
stimulated	NULL
with	NULL
hIL-9	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
1	NULL
h.	NULL
Total	NULL
RNAs	NULL
were	NULL
isolated	NULL
from	NULL
cells	NULL
using	NULL
a	NULL
guanidinium	NULL
isothiocyanate	NULL
method	NULL
(	NULL
28	NULL
)	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
used	NULL
for	NULL
Northern	NULL
blot	NULL
and	NULL
hybridized	NULL
with	NULL
*°P	NULL
-labeled	NULL
c-myc	NULL
,	NULL
junB	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
c-fos	NULL
cDNAs	NULL
.	NULL

The	NULL
mouse	NULL
glyceralde-	NULL
hyde-3-phosphate	NULL
dehydrogenase	NULL
probe	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
same	NULL
filters	NULL
to	NULL
ensure	NULL
equal	NULL
loading	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
different	NULL
pFlagIL-9R	NULL
constructs	NULL
in	NULL
TS1	NULL
transfectants	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
hIL-9Ra	NULL
cDNA	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

Gel	NULL
Shift	NULL
and	NULL
Gel	NULL
Supershift	NULL
Assoys-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
TS1	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

A	NULL
*°P-labeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
a	NULL
high	NULL
affinity	NULL
dyed	NULL
symmetrical	NULL
acute-phase	NULL
response	NULL
factor	NULL
(	NULL
APRF	NULL
)	NULL
binding	NULL
site	NULL
(	NULL
5'-CCTTCCCGGAATTC-3	NULL
'	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
(	NULL
25	NULL
)	NULL
.	NULL

For	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
[	NULL
d	NULL
(	NULL
I-C	NULL
)	NULL
]	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cpm	NULL
of	NULL
probe	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
,	NULL
the	NULL
reactions	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

For	NULL
the	NULL
gel	NULL
supershift	NULL
assay	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
anti-Stat8	NULL
antibody	NULL
or	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
preimmune	NULL
IgG	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
2	NULL
h	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
probe	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

In	NULL
oligonucleotide	NULL
competition	NULL
experiments	NULL
,	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
various	NULL
competitors	NULL
were	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
for	NULL
10	NULL
min	NULL
before	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
e-sis-inducible	NULL
element	NULL
(	NULL
SIE	NULL
)	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
Oct-1	NULL
competitors	NULL
are	NULL
:	NULL
SIE	NULL
,	NULL
5'-GTCGACATTTCCCGTAAATCTTGT-3	NULL
'	NULL
(	NULL
11	NULL
,	NULL
26	NULL
)	NULL
,	NULL
AP-1	NULL
,	NULL
5-CGCTT-GATGAGTCAGCCGGAA-3	NULL
'	NULL
(	NULL
Promega	NULL
)	NULL
;	NULL
Oct-1	NULL
,	NULL
5'-TGTCGAATGCA-AATCACTAGAA-3	NULL
'	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

RESULTS	NULL
Expression	NULL
of	NULL
Mutant	NULL
hIL-I9Ra	NULL
Proteins-To	NULL
identify	NULL
structural	NULL
elements	NULL
critical	NULL
for	NULL
IL-9-mediated	NULL
cell	NULL
proliferation	NULL
and	NULL
signal	NULL
transduction	NULL
in	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
hIL-9Ra	NULL
,	NULL
a	NULL
series	NULL
of	NULL
mutants	NULL
with	NULL
deletions	NULL
or	NULL
point	NULL
mutations	NULL
in	NULL
hIL-9Ra	NULL
were	NULL
constructed	NULL
and	NULL
stably	NULL
transfected	NULL
into	NULL
TS1	NULL
cells	NULL
.	NULL

TS1	NULL
is	NULL
a	NULL
mouse	NULL
IL-9-dependent	NULL
T	NULL
cell	NULL
line	NULL
that	NULL
does	NULL
not	NULL
respond	NULL
to	NULL
hIL-9	NULL
stimulation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
that	NULL
transfec-tion	NULL
of	NULL
hIL-9Ra	NULL
cDNA	NULL
into	NULL
TS1	NULL
cells	NULL
conferred	NULL
responsiveness	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
hIL-9	NULL
(	NULL
14	NULL
)	NULL
.	NULL

A	NULL
schematic	NULL
diagram	NULL
of	NULL
mutant	NULL
receptor	NULL
constructs	NULL
used	NULL
in	NULL
the	NULL
present	NULL
study	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
expression	NULL
of	NULL
different	NULL
pFlagIL-9R	NULL
constructs	NULL
in	NULL
transfected	NULL
TS1	NULL
cells	NULL
,	NULL
Northern	NULL
blot	NULL
and	NULL
immunoprecipitation	NULL
analysis	NULL
were	NULL
performed	NULL
to	NULL
detect	NULL
hIL-9R	NULL
mRNAs	NULL
and	NULL
proteins	NULL
in	NULL
different	NULL
transfectants	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
the	NULL
parental	NULL
TS1	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
hIL-9R	NULL
«	NULL
transcripts	NULL
and	NULL
proteins	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
different	NULL
pFlagIL-9R	NULL
constructs	NULL
expressed	NULL
various	NULL
sizes	NULL
of	NULL
hIL-9Ra	NULL
«	NULL
mRNAs	NULL
and	NULL
proteins	NULL
.	NULL

It	NULL
was	NULL
noticed	NULL
that	NULL
two	NULL
different	NULL
sizes	NULL
of	NULL
hIL-9Ra	NULL
proteins	NULL
were	NULL
expressed	NULL
in	NULL
each	NULL
transfectant	NULL
,	NULL
which	NULL
may	NULL
represent	NULL
different	NULL
glycosylated	NULL
forms	NULL
of	NULL
hIL-9Ra	NULL
«	NULL
.	NULL

Cell	NULL
surface	NULL
expression	NULL
of	NULL
FlagIL-9R	NULL
proteins	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
pRe/CMV	NULL
vector	NULL
alone	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
showed	NULL
a	NULL
similar	NULL
fluorescence	NULL
intensity	NULL
to	NULL
untransfected	NULL
cells	NULL
,	NULL
whereas	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
21336	NULL
$	NULL
&	NULL
&	NULL
p	NULL
&	NULL
&	NULL
ps	NULL
pe	NULL
4	NULL
&	NULL
§	NULL
c	NULL
w	NULL
D1	NULL
D2	NULL
-28S	NULL
-188	NULL
IL-9	NULL
Receptor	NULL
a	NULL
Domains	NULL
Critical	NULL
for	NULL
Signal	NULL
Transduction	NULL
B	NULL
Kd	NULL
w	NULL
#	NULL
pi	NULL
D2	NULL
D3	NULL
Da	NULL
§	NULL
$	NULL
C	NULL
108-	NULL
83-	NULL
50-	NULL
I	NULL
.	NULL

35	NULL
IP	NULL
:	NULL
anti-Flag	NULL
M2	NULL
Blot	NULL
:	NULL
anti-hIL-9R	NULL
100	NULL
80	NULL
i	NULL
Counts	NULL
10	NULL
10	NULL
)	NULL
60	NULL
80	NULL
100	NULL
)	NULL
i	NULL
Lillis	NULL
Counts	NULL
40	NULL
g	NULL
G8	NULL
errr	NULL
rico	NULL
10°	NULL
10°	NULL
10+	NULL
10°	NULL
10	NULL
)	NULL
10°	NULL
10°	NULL
10+	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Control	NULL
Flag	NULL
IL-9R	NULL
D2	NULL
FITC	NULL
Flag	NULL
IL-9R	NULL
STAT3m	NULL
FITC	NULL
g	NULL
8	NULL
8	NULL
24	NULL
1	NULL
si	NULL
©	NULL
,	NULL
I	NULL
a	NULL
8	NULL
287	NULL
#	NULL
81	NULL
\	NULL
:	NULL
£11	NULL
|	NULL
s	NULL
891	NULL
|	NULL
_	NULL
891	NULL
,	NULL
§e	NULL
``	NULL
m	NULL
it	NULL
1	NULL
‘	NULL
``	NULL
0	NULL
lai	NULL
p	NULL
¢	NULL
5	NULL
s	NULL
*	NULL
y	NULL
0	NULL
}	NULL
.	NULL

po	NULL
r	NULL
4	NULL
10°	NULL
10	NULL
)	NULL
10°	NULL
10°	NULL
10+	NULL
10°	NULL
10°	NULL
102	NULL
10°	NULL
10+	NULL
10°	NULL
10	NULL
)	NULL
10	NULL
10	NULL
10	NULL
Flag	NULL
IL-9R	NULL
W	NULL
FITC	NULL
Flag	NULL
IL-9R	NULL
D3	NULL
FITC	NULL
Flag	NULL
IL-9R	NULL
BOXm	NULL
FITC	NULL
‘	NULL
g	NULL
'	NULL
\	NULL
'	NULL
8	NULL
‘	NULL
7	NULL
‘	NULL
8	NULL
'	NULL
t	NULL
s	NULL
]	NULL
=	NULL
!	NULL
``	NULL

s3	NULL
#	NULL
1	NULL
||	NULL
a	NULL
8	NULL
£81	NULL
#	NULL
81	NULL
|	NULL
£	NULL
#	NULL
a	NULL
i	NULL
8	NULL
a	NULL
s	NULL
094	NULL
89	NULL
:	NULL
AA	NULL
&	NULL
:	NULL
81	NULL
i	NULL
§	NULL
4	NULL
,	NULL
f	NULL
0	NULL
1s	NULL
s	NULL
,	NULL
o	NULL
Toos	NULL
.	NULL

o	NULL
4.	NULL
rane	NULL
{	NULL
o	NULL
a	NULL
pe	NULL
10°	NULL
102	NULL
Flag	NULL
IL-9R	NULL
D1	NULL
FITC	NULL
r	NULL
T	NULL
10°	NULL
%	NULL
orie	NULL
10	NULL
)	NULL
102	NULL
10°	NULL
Flag	NULL
IL-9R	NULL
D4	NULL
FITC	NULL
10	NULL
10	NULL
102	NULL
10°	NULL
104	NULL
Flag	NULL
IL-9R	NULL
BOXd	NULL
FITC	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Expression	NULL
of	NULL
different	NULL
pFlagIL-9Ra	NULL
constructs	NULL
in	NULL
TS1	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
northern	NULL
blot	NULL
analysis	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
untransfected	NULL
TS1	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
and	NULL
transfected	NULL
TS1	NULL
cells	NULL
with	NULL
different	NULL
pFlagIL-9R	NULL
constructs	NULL
were	NULL
size-fractionated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
*°P-labeled	NULL
hIL-9Ra	NULL
cDNA	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
immunoprecipitation	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
lysates	NULL
from	NULL
about	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
of	NULL
different	NULL
transfectants	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Flag2	NULL
antibody	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
PVDF	NULL
membrane	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-hIL-9R	NULL
antibody	NULL
.	NULL

Kd	NULL
,	NULL
kilodalton	NULL
;	NULL
ZP	NULL
,	NULL
immunoprecipitation	NULL
analysis	NULL
.	NULL

C	NULL
,	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

Surface	NULL
expression	NULL
of	NULL
FlagIL-9R	NULL
proteins	NULL
was	NULL
demonstrated	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

Various	NULL
TS1	NULL
transfectants	NULL
were	NULL
incubated	NULL
sequentially	NULL
with	NULL
anti-Flag	NULL
M2	NULL
and	NULL
anti-mouse-IgG1-fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
antibodies	NULL
.	NULL

Dashed	NULL
lines	NULL
represent	NULL
fluorescence	NULL
intensity	NULL
of	NULL
untransfected	NULL
TS1	NULL
cells	NULL
;	NULL
solid	NULL
Itnes	NULL
represent	NULL
fluorescence	NULL
intensity	NULL
shifts	NULL
with	NULL
transfected	NULL
cells	NULL
.	NULL

Control	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
vector	NULL
alone	NULL
.	NULL

transfectants	NULL
expressing	NULL
various	NULL
pFlagIL-9R	NULL
cDNAs	NULL
had	NULL
a	NULL
higher	NULL
relative	NULL
fluorescence	NULL
intensity	NULL
than	NULL
control	NULL
cells	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
positive	NULL
cells	NULL
was	NULL
very	NULL
similar	NULL
among	NULL
different	NULL
transfectants	NULL
.	NULL

Two	NULL
Regions	NULL
in	NULL
the	NULL
Cytoplasmic	NULL
Domain	NULL
of	NULL
IL-9Ra	NULL
Play	NULL
Important	NULL
Roles	NULL
in	NULL
IL-9-induced	NULL
Cell	NULL
Growth-To	NULL
understand	NULL
the	NULL
role	NULL
of	NULL
different	NULL
regions	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
in	NULL
hIL-	NULL
9Ra	NULL
for	NULL
IL-9-mediated	NULL
cell	NULL
growth	NULL
,	NULL
TS1	NULL
cells	NULL
transfected	NULL
with	NULL
different	NULL
hIL-9Ra	NULL
cDNAs	NULL
were	NULL
tested	NULL
for	NULL
their	NULL
proliferative	NULL
response	NULL
to	NULL
various	NULL
concentrations	NULL
of	NULL
hIL-9	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
vector	NULL
alone	NULL
did	NULL
not	NULL
grow	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hIL-9	NULL
;	NULL
in	NULL
fact	NULL
,	NULL
>	NULL
95	NULL
%	NULL
of	NULL
cells	NULL
were	NULL
dead	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
®H	NULL
)	NULL
thymidine	NULL
.	NULL

TS1	NULL
cells	NULL
transfected	NULL
with	NULL
wild-type	NULL
hIL-I9Ra	NULL
(	NULL
pFlagIL-9R	NULL
W	NULL
)	NULL
showed	NULL
a	NULL
strong	NULL
response	NULL
to	NULL
hIL-9	NULL
induction	NULL
,	NULL
IL-9	NULL
Receptor	NULL
a	NULL
Domains	NULL
Critical	NULL
for	NULL
Signal	NULL
Transduction	NULL
FlagIL-9R	NULL
W	NULL
FlagiL-9R	NULL
D+	NULL
f	NULL
FlagIL-9R	NULL
D2	NULL
(	NULL
FlagiL-9R	NULL
D3	NULL
FlagIL-9R	NULL
D4	NULL
FlagIL-9R	NULL
BOXm	NULL
FlagiL-9R	NULL
STAT3m	NULL
&	NULL
FlaglL-9	NULL
BOXd	NULL
f	NULL
vector	NULL
alone	NULL
H	NULL
0	NULL
20000	NULL
40000	NULL
_	NULL
80000	NULL
-	NULL
80000	NULL
100000	NULL
[	NULL
]	NULL
o	NULL
04	NULL
[	NULL
¥	NULL
:	NULL
hIL-9	NULL
conc	NULL
.	NULL

(	NULL
ng/ml	NULL
)	NULL
Fic	NULL
.	NULL

3.	NULL
hIL-9-dependent	NULL
DNA	NULL
synthesis	NULL
of	NULL
TS1	NULL
transfectants	NULL
expressing	NULL
hIL-9Ra	NULL
.	NULL

TSl	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
different	NULL
pFlagIL-9R	NULL
constructs	NULL
or	NULL
vector	NULL
alone	NULL
were	NULL
cultured	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
hIL-9	NULL
,	NULL
and	NULL
incorporation	NULL
of	NULL
into	NULL
cells	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
here	NULL
represent	NULL
the	NULL
mean	NULL
values	NULL
in	NULL
a	NULL
typical	NULL
experiment	NULL
with	NULL
triplicates	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

with	NULL
cell	NULL
proliferation	NULL
detected	NULL
even	NULL
at	NULL
a	NULL
very	NULL
low	NULL
concentration	NULL
of	NULL
hIL-9	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
FlagIL-9R	NULL
fusion	NULL
protein	NULL
functioned	NULL
like	NULL
the	NULL
natural	NULL
form	NULL
of	NULL
hIL-9Ra	NULL
in	NULL
response	NULL
to	NULL
hIL-9	NULL
stimulation	NULL
in	NULL
TS1	NULL
cells	NULL
.	NULL

Transfectants	NULL
harboring	NULL
pFlagIL-9R	NULL
D1	NULL
and	NULL
pFlagIL-9R	NULL
D2	NULL
(	NULL
D1	NULL
and	NULL
D2	NULL
)	NULL
showed	NULL
a	NULL
proliferative	NULL
response	NULL
comparable	NULL
to	NULL
wild-type	NULL
transfectants	NULL
,	NULL
suggesting	NULL
that	NULL
distal	NULL
C	NULL
terminus	NULL
and	NULL
the	NULL
serine-rich	NULL
region	NULL
of	NULL
hIL-9Ra	NULL
are	NULL
dispensable	NULL
for	NULL
IL-Q9-induced	NULL
cell	NULL
proliferation	NULL
.	NULL

This	NULL
is	NULL
in	NULL
part	NULL
different	NULL
from	NULL
IL-2Rf	NULL
in	NULL
which	NULL
the	NULL
serine-rich	NULL
region	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
IL-2-induced	NULL
cell	NULL
growth	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Two	NULL
regions	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
hIL-9Ra	NULL
were	NULL
implicated	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
IL-9-mediated	NULL
cell	NULL
proliferation	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

A	NULL
membrane-proximal	NULL
region	NULL
between	NULL
amino	NULL
acids	NULL
295	NULL
and	NULL
338	NULL
including	NULL
a	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
.	NULL

The	NULL
proliferative	NULL
response	NULL
to	NULL
IL-9	NULL
was	NULL
abrogated	NULL
when	NULL
this	NULL
region	NULL
was	NULL
further	NULL
truncated	NULL
(	NULL
D4	NULL
)	NULL
or	NULL
if	NULL
the	NULL
BOX1	NULL
motif	NULL
in	NULL
this	NULL
region	NULL
was	NULL
deleted	NULL
(	NULL
BOXd	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
in	NULL
hIL-9Ra	NULL
is	NULL
required	NULL
for	NULL
IL-9-mediated	NULL
cell	NULL
growth	NULL
.	NULL

However	NULL
,	NULL
unlike	NULL
other	NULL
receptor	NULL
systems	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
Pro-X-Pro	NULL
motif	NULL
in	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
of	NULL
hIL-9Ra	NULL
(	NULL
BOXm	NULL
)	NULL
did	NULL
not	NULL
abolish	NULL
but	NULL
slightly	NULL
reduced	NULL
IL-9-mediated	NULL
cell	NULL
growth	NULL
.	NULL

The	NULL
second	NULL
important	NULL
region	NULL
is	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
between	NULL
amino	NULL
acids	NULL
338	NULL
and	NULL
422	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
a	NULL
STAT3	NULL
binding	NULL
site	NULL
and	NULL
was	NULL
found	NULL
to	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
promoting	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
.	NULL

When	NULL
this	NULL
region	NULL
was	NULL
truncated	NULL
(	NULL
D3	NULL
)	NULL
,	NULL
cells	NULL
only	NULL
proliferated	NULL
at	NULL
a	NULL
higher	NULL
concentration	NULL
of	NULL
hIL-9	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
.	NULL

Since	NULL
STAT	NULL
3	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
only	NULL
STAT	NULL
protein	NULL
activated	NULL
by	NULL
IL-9	NULL
in	NULL
TS1	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
,	NULL
we	NULL
also	NULL
mutated	NULL
STAT3	NULL
binding	NULL
site	NULL
within	NULL
the	NULL
hIL-9Ra	NULL
to	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
STAT3	NULL
in	NULL
IL-9-mediated	NULL
cell	NULL
growth	NULL
.	NULL

Interestingly	NULL
,	NULL
point	NULL
mutation	NULL
at	NULL
the	NULL
STAT3	NULL
binding	NULL
site	NULL
from	NULL
YLPQ	NULL
to	NULL
YLPA	NULL
(	NULL
STAT3	NULL
m	NULL
transfectants	NULL
)	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
,	NULL
although	NULL
a	NULL
similar	NULL
point	NULL
mutation	NULL
(	NULL
from	NULL
YMPQ	NULL
to	NULL
YMPA	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
abolish	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
induced	NULL
by	NULL
gp130	NULL
family	NULL
of	NULL
cyto-kines	NULL
(	NULL
28	NULL
)	NULL
.	NULL

We	NULL
also	NULL
noticed	NULL
that	NULL
wild	NULL
type	NULL
,	NULL
D1	NULL
,	NULL
D2	NULL
,	NULL
and	NULL
STAT3	NULL
m	NULL
transfectants	NULL
had	NULL
a	NULL
higher	NULL
incidence	NULL
of	NULL
becoming	NULL
factor-independent	NULL
compared	NULL
with	NULL
D3	NULL
,	NULL
D4	NULL
,	NULL
BOXm	NULL
,	NULL
and	NULL
BOXd	NULL
trans-	NULL
21337	NULL
fectants	NULL
,	NULL
implicating	NULL
that	NULL
overexpression	NULL
of	NULL
specific	NULL
domains	NULL
of	NULL
IL-9Ra	NULL
«	NULL
may	NULL
result	NULL
in	NULL
transformation	NULL
of	NULL
TS1	NULL
cells	NULL
.	NULL

Deletion	NULL
of	NULL
Two	NULL
Regions	NULL
in	NULL
the	NULL
Cytoplasmic	NULL
Domain	NULL
of	NULL
hIL-Abrogates	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
JAK	NULL
Kinases	NULL
,	NULL
IRS-2	NULL
,	NULL
and	NULL
STAT3	NULL
Induced	NULL
by	NULL
hIL-9-Accumulated	NULL
evidence	NULL
has	NULL
revealed	NULL
that	NULL
molecular	NULL
cascades	NULL
involved	NULL
in	NULL
cytokine-mediated	NULL
cell	NULL
growth	NULL
are	NULL
associated	NULL
with	NULL
protein	NULL
tyrosine	NULL
phos-phorylation	NULL
.	NULL

JAK1	NULL
,	NULL
JAK3	NULL
,	NULL
IRS-2	NULL
,	NULL
and	NULL
STAT3	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
IL-9	NULL
stimulation	NULL
through	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
our	NULL
previous	NULL
studies	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
hIL-9Ra	NULL
in	NULL
IL-9-induced	NULL
growth-promoting	NULL
signals	NULL
,	NULL
the	NULL
status	NULL
of	NULL
hIL-9-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
,	NULL
IRS-2	NULL
,	NULL
or	NULL
STAT3	NULL
in	NULL
TS1	NULL
cells	NULL
expressing	NULL
wild-type	NULL
and	NULL
mutant	NULL
hIL-9Ras	NULL
were	NULL
tested	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
,	NULL
JAK3	NULL
,	NULL
IRS-2	NULL
,	NULL
and	NULL
STAT3	NULL
was	NULL
comparable	NULL
in	NULL
wild-type	NULL
hIL-9Ra	NULL
transfectants	NULL
(	NULL
W	NULL
)	NULL
and	NULL
in	NULL
parental	NULL
TS1	NULL
cells	NULL
stimulated	NULL
with	NULL
hIL-9	NULL
and	NULL
mIL-9	NULL
,	NULL
respectively	NULL
,	NULL
indicating	NULL
that	NULL
transfected	NULL
hIL-9Ra	NULL
transduces	NULL
similar	NULL
signals	NULL
as	NULL
its	NULL
murine	NULL
counterpart	NULL
following	NULL
hIL-9	NULL
stimulation	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
C	NULL
terminus	NULL
and	NULL
the	NULL
serine-rich	NULL
region	NULL
of	NULL
hIL-9Ra	NULL
«	NULL
(	NULL
D1	NULL
and	NULL
D2	NULL
)	NULL
failed	NULL
to	NULL
change	NULL
hIL-9-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
,	NULL
IRS-2	NULL
,	NULL
and	NULL
STAT3	NULL
.	NULL

The	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
membrane-proximal	NULL
region	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
absolutely	NULL
required	NULL
for	NULL
IL-9-induced	NULL
signaling	NULL
,	NULL
since	NULL
truncation	NULL
(	NULL
D4	NULL
)	NULL
or	NULL
internal	NULL
deletion	NULL
(	NULL
BOXd	NULL
)	NULL
of	NULL
this	NULL
region	NULL
completely	NULL
abolished	NULL
IL-9-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
,	NULL
IRS-2	NULL
,	NULL
and	NULL
STAT3	NULL
.	NULL

Furthermore	NULL
,	NULL
point	NULL
mutation	NULL
of	NULL
Pro-X-Pro	NULL
motif	NULL
into	NULL
Ala-X-Ala	NULL
(	NULL
BOXm	NULL
)	NULL
within	NULL
the	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
also	NULL
decreased	NULL
IL-9-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
,	NULL
IRS-2	NULL
,	NULL
and	NULL
STAT3	NULL
.	NULL

It	NULL
was	NULL
also	NULL
found	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
and	NULL
IRS-2	NULL
was	NULL
greatly	NULL
decreased	NULL
when	NULL
the	NULL
BOX1	NULL
downstream	NULL
region	NULL
of	NULL
hIL-9Ra	NULL
was	NULL
truncated	NULL
(	NULL
D3	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
,	NULL
in	NULL
which	NULL
the	NULL
BOX1	NULL
downstream	NULL
region	NULL
of	NULL
hIL-9Ra	NULL
was	NULL
found	NULL
to	NULL
be	NULL
absolutely	NULL
required	NULL
for	NULL
IL-9-induced	NULL
JAK1	NULL
activation	NULL
in	NULL
BW	NULL
5147	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

This	NULL
region	NULL
was	NULL
also	NULL
found	NULL
to	NULL
be	NULL
indispensable	NULL
for	NULL
activation	NULL
of	NULL
STAT3	NULL
,	NULL
since	NULL
truncation	NULL
of	NULL
this	NULL
region	NULL
eliminated	NULL
IL-9-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
D3	NULL
)	NULL
.	NULL

Point	NULL
mutation	NULL
of	NULL
the	NULL
STAT3	NULL
binding	NULL
motif	NULL
from	NULL
YLPQ	NULL
to	NULL
YLPA	NULL
in	NULL
this	NULL
region	NULL
(	NULL
Stat3	NULL
m	NULL
)	NULL
greatly	NULL
decreased	NULL
IL-9-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
,	NULL
suggesting	NULL
activation	NULL
of	NULL
STAT3	NULL
is	NULL
most	NULL
likely	NULL
through	NULL
this	NULL
YLPQ	NULL
motif	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
status	NULL
of	NULL
STAT3	NULL
activation	NULL
by	NULL
hIL-9	NULL
in	NULL
different	NULL
hIL-9Ra	NULL
transfectants	NULL
,	NULL
gel	NULL
shift	NULL
and	NULL
gel	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
detect	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
following	NULL
hIL-9	NULL
stimulation	NULL
.	NULL

As	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
wild-type	NULL
transfectants	NULL
stimulated	NULL
by	NULL
hIL-9	NULL
specifically	NULL
bind	NULL
to	NULL
the	NULL
APRF	NULL
sequence	NULL
that	NULL
has	NULL
a	NULL
high	NULL
affinity	NULL
binding	NULL
site	NULL
for	NULL
STAT3	NULL
proteins	NULL
(	NULL
25	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
activity	NULL
was	NULL
induced	NULL
within	NULL
1	NULL
min	NULL
after	NULL
hIL-9	NULL
stimulation	NULL
and	NULL
persisted	NULL
for	NULL
at	NULL
least	NULL
15	NULL
min	NULL
.	NULL

The	NULL
competition	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
APRF	NULL
binding	NULL
activity	NULL
induced	NULL
by	NULL
IL-9	NULL
could	NULL
be	NULL
completely	NULL
blocked	NULL
with	NULL
100-fold	NULL
excess	NULL
of	NULL
cold	NULL
APRF	NULL
or	NULL
SIE	NULL
competitor	NULL
but	NULL
not	NULL
with	NULL
100-fold	NULL
excess	NULL
of	NULL
AP-1	NULL
or	NULL
Oct-1	NULL
oligonucleotide	NULL
.	NULL

It	NULL
was	NULL
further	NULL
shown	NULL
by	NULL
the	NULL
gel	NULL
supershift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
that	NULL
most	NULL
of	NULL
the	NULL
IL-9-induced	NULL
APRF-protein	NULL
complexes	NULL
can	NULL
be	NULL
specifically	NULL
supershifted	NULL
by	NULL
anti-STAT3	NULL
antibody	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
major	NULL
proteins	NULL
in	NULL
IL-9-induced	NULL
APREF-protein	NULL
complexes	NULL
are	NULL
STAT3	NULL
or	NULL
STAT3-related	NULL
mole-cules	NULL
.	NULL

IL-9-induced	NULL
APRF	NULL
binding	NULL
activities	NULL
were	NULL
also	NULL
examined	NULL
in	NULL
different	NULL
hIL-9R	NULL
transfectants	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
;	NULL
it	NULL
was	NULL
found	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
APRF	NULL
binding	NULL
activities	NULL
correlated	NULL
with	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
these	NULL
transfectants	NULL
following	NULL
IL-9	NULL
stimulation	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
21338	NULL
IL-9	NULL
Receptor	NULL
a	NULL
Domains	NULL
Critical	NULL
for	NULL
Signal	NULL
Transduction	NULL
TSl	NULL
w	NULL
D1	NULL
D2	NULL
D3	NULL
D4	NULL
BOXm	NULL
STAT3m	NULL
BOXd	NULL
hIL-9	NULL
;	NULL
£00	NULL
.	NULL

00	NULL
}	NULL
0	NULL
$	NULL
40+	NULL
pol	NULL
o	NULL
$	NULL
ok	NULL
ook	NULL
$	NULL
o.	NULL
bo-	NULL
4	NULL
mIL-9	NULL
:	NULL
mo	NULL
¥	NULL
ok	NULL
ow	NULL
0	NULL
o	NULL
&	NULL
e	NULL
woow	NULL
oo	NULL
o	NULL
_	NULL
®	NULL
oko	NULL
&	NULL
&	NULL
o	NULL
>	NULL
oe	NULL
%	NULL
fd	NULL
cam	NULL
«	NULL
am	NULL
«	NULL
wom	NULL
cam	NULL
am	NULL
IP	NULL
;	NULL
JAK1	NULL
BLOT	NULL
:	NULL
P-Tyr	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
,	NULL
JAK3	NULL
,	NULL
IRS-2	NULL
,	NULL
and	NULL
STAT3	NULL
in	NULL
TS1	NULL
transfectants	NULL
expressing	NULL
hIL-9Ra	NULL
.	NULL

Cells	NULL
were	NULL
starved	NULL
in	NULL
serum-free	NULL
medium	NULL
for	NULL
8	NULL
h.	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
not	NULL
stimulated	NULL
or	NULL
stimulated	NULL
with	NULL
hIL-9	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
5	NULL
min	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
1.5	NULL
ug	NULL
of	NULL
anti-JAK1	NULL
,	NULL
JAK83	NULL
,	NULL
or	NULL
STAT3	NULL
or	NULL
4	NULL
ug	NULL
of	NULL
anti-IRS-2	NULL
antibody	NULL
at	NULL
4°C	NULL
overnight	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electro-phoresis	NULL
and	NULL
transferred	NULL
to	NULL
PVDF	NULL
mem-branes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
P-Tyr	NULL
)	NULL
,	NULL
anti-JAK1	NULL
,	NULL
anti-JAK8	NULL
,	NULL
anti-IRS-2	NULL
,	NULL
and	NULL
anti-STAT3	NULL
.	NULL

IP	NULL
:	NULL
JAK1	NULL
BLOT	NULL
:	NULL
JAK1	NULL
IP	NULL
:	NULL
JAK3	NULL
BLOT	NULL
:	NULL
P-Tyr	NULL
IP	NULL
:	NULL
JAK3	NULL
BLOT	NULL
:	NULL
JAK3	NULL
k	NULL
IP	NULL
:	NULL
IRS-2	NULL
BLOT	NULL
:	NULL
P-Ty	NULL
:	NULL
(	NULL
®	NULL
@	NULL
I	NULL
ams	NULL
HJ	NULL
us	NULL
Shiu	NULL
as	NULL
us	NULL
Bis	NULL
wal	NULL
l	NULL
=	NULL
%	NULL
=s	NULL
#	NULL
#	NULL
-..	NULL
as	NULL
--	NULL
&	NULL
-	NULL
WARM	NULL
-	NULL
a	NULL
-	NULL
t	NULL
T	NULL
t.	NULL
ms	NULL
2.	NULL
stom	NULL
ms	NULL
o	NULL
eee	NULL
oa	NULL
e	NULL
a	NULL
IP	NULL
:	NULL
STAT3	NULL
BLOT	NULL
:	NULL
P-Tyr	NULL
~	NULL
»	NULL
«	NULL
#	NULL
p	NULL
twat	NULL
cas	NULL
f	NULL
I	NULL
care	NULL
«	NULL
ir	NULL
:	NULL
stats	NULL
stor	NULL
:	NULL
stars	NULL
CE	NULL
Different	NULL
Signaling	NULL
Molecules	NULL
Are	NULL
Involved	NULL
in	NULL
the	NULL
Activation	NULL
of	NULL
c-Myc	NULL
and	NULL
JunB	NULL
by	NULL
hIL-9-Activation	NULL
of	NULL
primary	NULL
response	NULL
genes	NULL
,	NULL
which	NULL
are	NULL
signaling	NULL
events	NULL
downstream	NULL
of	NULL
JAK/STAT	NULL
activation	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

hIL-9	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
induce	NULL
c-Myc	NULL
and	NULL
JunB	NULL
expression	NULL
in	NULL
a	NULL
human	NULL
megakaryo-cytic	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
19	NULL
)	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
intracellular	NULL
domains	NULL
of	NULL
hIL-9Ra	NULL
«	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
primary	NULL
response	NULL
genes	NULL
and	NULL
to	NULL
correlate	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
with	NULL
cell	NULL
growth	NULL
,	NULL
we	NULL
examined	NULL
expression	NULL
of	NULL
c-mye	NULL
,	NULL
jun	NULL
B	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
c-fos	NULL
in	NULL
response	NULL
to	NULL
hIL-9	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

It	NULL
was	NULL
observed	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
hIL-9	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
expression	NULL
of	NULL
c-mye	NULL
and	NULL
junB	NULL
mRNAs	NULL
was	NULL
up-regulated	NULL
in	NULL
wild-type	NULL
,	NULL
D1	NULL
,	NULL
and	NULL
D2	NULL
transfectants	NULL
upon	NULL
stimulation	NULL
with	NULL
hIL-9	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
e-mye	NULL
and	NULL
junB	NULL
were	NULL
not	NULL
induced	NULL
in	NULL
D4	NULL
,	NULL
D3	NULL
,	NULL
and	NULL
BOXd	NULL
transfectants	NULL
,	NULL
suggesting	NULL
the	NULL
membrane-proximal	NULL
region	NULL
and	NULL
the	NULL
adjacent	NULL
downstream	NULL
region	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
hIL-9Ra	NULL
are	NULL
indispensable	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
c-myc	NULL
and	NULL
junB	NULL
.	NULL

In	NULL
BOXm	NULL
transfectants	NULL
,	NULL
induction	NULL
of	NULL
both	NULL
e-mye	NULL
and	NULL
junB	NULL
genes	NULL
by	NULL
hIL-9	NULL
was	NULL
greatly	NULL
reduced	NULL
compared	NULL
with	NULL
wild-type	NULL
transfectants	NULL
,	NULL
indicating	NULL
downstream	NULL
signaling	NULL
molecules	NULL
associated	NULL
with	NULL
the	NULL
Pro-X-Pro	NULL
motif	NULL
may	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
c-myc	NULL
and	NULL
junB	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
STAT3	NULL
m	NULL
transfectants	NULL
,	NULL
induction	NULL
of	NULL
e-mye	NULL
was	NULL
greatly	NULL
diminished	NULL
,	NULL
whereas	NULL
the	NULL
expression	NULL
of	NULL
junB	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
,	NULL
suggesting	NULL
that	NULL
activation	NULL
of	NULL
c-myc	NULL
and	NULL
junB	NULL
by	NULL
hIL-9	NULL
is	NULL
mediated	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
different	NULL
mechanisms	NULL
.	NULL

DISCUSSION	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
hIL-9Ra	NULL
in	NULL
IL-9-mediated	NULL
cell	NULL
proliferation	NULL
and	NULL
signal	NULL
transduction	NULL
.	NULL

We	NULL
identified	NULL
two	NULL
re-gions	NULL
,	NULL
a	NULL
membrane-proximal	NULL
region	NULL
containing	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
and	NULL
the	NULL
adjacent	NULL
downstream	NULL
region	NULL
containing	NULL
a	NULL
STAT3	NULL
binding	NULL
site	NULL
,	NULL
as	NULL
required	NULL
for	NULL
IL-9-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

In	NULL
our	NULL
study	NULL
,	NULL
the	NULL
membrane-proximal	NULL
region	NULL
including	NULL
47	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
hIL-9Ra	NULL
«	NULL
(	NULL
D3	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
support	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
even	NULL
though	NULL
the	NULL
response	NULL
of	NULL
this	NULL
mutant	NULL
to	NULL
IL-9	NULL
was	NULL
greatly	NULL
reduced	NULL
compared	NULL
with	NULL
wild	NULL
type	NULL
hIL-9Ra	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
different	NULL
from	NULL
a	NULL
recent	NULL
report	NULL
by	NULL
Demoulin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
in	NULL
which	NULL
a	NULL
mouse	NULL
IL-3-dependent	NULL
cell	NULL
line	NULL
,	NULL
Ba/F3	NULL
,	NULL
transfected	NULL
with	NULL
truncated	NULL
hIL-9Ra	NULL
«	NULL
plasmid	NULL
encoding	NULL
115	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
cytoplasmic	NULL
region	NULL
containing	NULL
the	NULL
BOX1	NULL
motif	NULL
no	NULL
longer	NULL
responds	NULL
to	NULL
hIL-9	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
the	NULL
two	NULL
studies	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
cell	NULL
types	NULL
used	NULL
in	NULL
each	NULL
of	NULL
these	NULL
experiments	NULL
.	NULL

The	NULL
function	NULL
of	NULL
the	NULL
membrane-proximal	NULL
region	NULL
in	NULL
hIL-9Ra	NULL
«	NULL
is	NULL
most	NULL
likely	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
BOX1	NULL
motif	NULL
,	NULL
which	NULL
is	NULL
also	NULL
found	NULL
in	NULL
the	NULL
membrane-proximal	NULL
region	NULL
of	NULL
many	NULL
cytokine	NULL
receptors	NULL
and	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
important	NULL
for	NULL
JAKIJAK2	NULL
activation	NULL
and	NULL
cell	NULL
growth	NULL
in	NULL
several	NULL
cytokine	NULL
receptor	NULL
systems	NULL
(	NULL
30-34	NULL
)	NULL
.	NULL

In	NULL
our	NULL
study	NULL
,	NULL
truncation	NULL
or	NULL
internal	NULL
deletion	NULL
of	NULL
the	NULL
BOX1	NULL
motif	NULL
in	NULL
the	NULL
membrane-proximal	NULL
region	NULL
of	NULL
hIL-9Ra	NULL
totally	NULL
abolished	NULL
hIL-9-induced	NULL
cell	NULL
proliferation	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
and	NULL
JAK3	NULL
,	NULL
suggesting	NULL
the	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
in	NULL
hIL-9Ra	NULL
plays	NULL
a	NULL
preeminent	NULL
role	NULL
in	NULL
IL-9-induced	NULL
activation	NULL
of	NULL
JAK	NULL
kinases	NULL
and	NULL
cell	NULL
growth	NULL
.	NULL

Since	NULL
mutation	NULL
of	NULL
the	NULL
conserved	NULL
Pro-X-Pro	NULL
motif	NULL
in	NULL
the	NULL
BOX1	NULL
consensus	NULL
sequence	NULL
inactivated	NULL
the	NULL
receptor	NULL
and	NULL
JAK1	NULL
activation	NULL
in	NULL
certain	NULL
receptor	NULL
systems	NULL
(	NULL
30	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
we	NULL
also	NULL
introduced	NULL
point	NULL
mutations	NULL
(	NULL
Pro-X-Pro	NULL
to	NULL
Ala-X-Ala	NULL
)	NULL
in	NULL
the	NULL
BOX1l	NULL
consensus	NULL
sequence	NULL
of	NULL
hIL-9Ra	NULL
(	NULL
BOXm	NULL
)	NULL
.	NULL

To	NULL
our	NULL
surprise	NULL
,	NULL
these	NULL
mutations	NULL
did	NULL
not	NULL
totally	NULL
abolish	NULL
IL-9-mediated	NULL
cell	NULL
growth	NULL
,	NULL
but	NULL
decreased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
and	NULL
JAK3	NULL
.	NULL

Although	NULL
activation	NULL
of	NULL
JAK3	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
mainly	NULL
associated	NULL
with	NULL
IL-2R	NULL
y	NULL
chain	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
affected	NULL
by	NULL
mutations	NULL
in	NULL
the	NULL
membrane-proximal	NULL
and	NULL
the	NULL
BOX1	NULL
downstream	NULL
regions	NULL
of	NULL
hIL-9Ra	NULL
in	NULL
our	NULL
study	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
membrane-proximal	NULL
region	NULL
of	NULL
human	NULL
IL-2RB	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
JAKB3	NULL
activation	NULL
(	NULL
85	NULL
)	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
JAK3	NULL
may	NULL
bind	NULL
to	NULL
receptor	NULL
subunits	NULL
other	NULL
than	NULL
IL-2R	NULL
y	NULL
chain	NULL
for	NULL
its	NULL
activation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
also	NULL
investigated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-2	NULL
by	NULL
IL-9	NULL
in	NULL
various	NULL
transfectants	NULL
.	NULL

It	NULL
appears	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-2	NULL
correlated	NULL
with	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
earlier	NULL
observation	NULL
that	NULL
JAK	NULL
kinases	NULL
are	NULL
responsible	NULL
for	NULL
IL-9-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS	NULL
proteins	NULL
(	NULL
18	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
study	NULL
by	NULL
Demoulin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
,	NULL
our	NULL
data	NULL
also	NULL
indicated	NULL
that	NULL
the	NULL
BOX1	NULL
downstream	NULL
region	NULL
in	NULL
hIL-9Ra	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
IL-9-mediated	NULL
cell	NULL
growth	NULL
.	NULL

Deletion	NULL
of	NULL
this	NULL
region	NULL
not	NULL
only	NULL
greatly	NULL
reduced	NULL
hIL-9-stimulated	NULL
cell	NULL
proliferation	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
and	NULL
IRS-2	NULL
but	NULL
also	NULL
abrogated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

A	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
IL-9	NULL
Receptor	NULL
a	NULL
Domains	NULL
Critical	NULL
for	NULL
Signal	NULL
Transduction	NULL
A	NULL
B	NULL
0	NULL
1	NULL
3	NULL
50	NULL
15	NULL
Min	NULL
.	NULL

Comp	NULL
.	NULL

>	NULL
#	NULL
#	NULL
an	NULL
Pre	NULL
IgG	NULL
s	NULL
Anti-Stat3	NULL
#	NULL
-*-	NULL
#	NULL
»	NULL
~	NULL
@	NULL
*	NULL
*~**M08	NULL
#	NULL
4	NULL
=	NULL
>	NULL
4	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Activation	NULL
of	NULL
STAT3	NULL
by	NULL
hIL-9	NULL
in	NULL
TS1	NULL
transfectants	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutant	NULL
hIL-9Ra	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
wild-type	NULL
hIL-9R	NULL
transfectants	NULL
treated	NULL
with	NULL
hIL-9	NULL
for	NULL
the	NULL
indicated	NULL
period	NULL
of	NULL
time	NULL
,	NULL
and	NULL
the	NULL
APRF	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
analyzed	NULL
by	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

B	NULL
,	NULL
gel	NULL
shift	NULL
and	NULL
gel	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
wild-type	NULL
hIL-9Ra	NULL
:	NULL
transfec-tant	NULL
stimulated	NULL
by	NULL
hIL-9	NULL
for	NULL
5	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitors	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
pre-immune	NULL
IgG	NULL
or	NULL
anti-STAT3	NULL
antibody	NULL
.	NULL

Comp	NULL
.	NULL

,	NULL
competitor	NULL
.	NULL

C	NULL
,	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
TS1	NULL
cells	NULL
stimulated	NULL
by	NULL
mIL-9	NULL
for	NULL
5	NULL
min	NULL
(	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
)	NULL
or	NULL
from	NULL
different	NULL
hIL-9Ra	NULL
transfectants	NULL
stimulated	NULL
by	NULL
hIL-9	NULL
for	NULL
5	NULL
min	NULL
.	NULL

STAT3	NULL
binding	NULL
site	NULL
(	NULL
YLPQ	NULL
)	NULL
was	NULL
found	NULL
within	NULL
this	NULL
region	NULL
.	NULL

YXXQ	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
gp130	NULL
family	NULL
receptors	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
the	NULL
important	NULL
role	NULL
of	NULL
the	NULL
tyrosine	NULL
residue	NULL
within	NULL
YLPQ	NULL
motif	NULL
in	NULL
hIL-9Ra	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
tyrosine	NULL
residue	NULL
within	NULL
this	NULL
motif	NULL
was	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
IL-9-mediated	NULL
cell	NULL
growth	NULL
and	NULL
activation	NULL
of	NULL
STAT1	NULL
«	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STATS5	NULL
,	NULL
STAT	NULL
factors	NULL
were	NULL
suggested	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
IL-9-mediated	NULL
cell	NULL
proliferation	NULL
.	NULL

However	NULL
,	NULL
in	NULL
our	NULL
study	NULL
,	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
this	NULL
STAT3	NULL
binding	NULL
site	NULL
from	NULL
YLPQ	NULL
to	NULL
YLPA	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
but	NULL
greatly	NULL
reduced	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STAT3	NULL
,	NULL
suggesting	NULL
that	NULL
STAT3	NULL
may	NULL
not	NULL
be	NULL
the	NULL
major	NULL
signaling	NULL
molecule	NULL
in	NULL
IL-9-induced	NULL
cell	NULL
growth	NULL
in	NULL
TS1	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
gp130	NULL
system	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
suggested	NULL
that	NULL
STAT3	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
cell	NULL
differentiation	NULL
and	NULL
growth	NULL
arrest	NULL
mediated	NULL
by	NULL
IL-6	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
also	NULL
investigated	NULL
primary	NULL
response	NULL
gene	NULL
expres-	NULL
21339	NULL
Transfectants	NULL
:	NULL
w	NULL
-	NULL
D1	NULL
D2	NULL
D3	NULL
D4	NULL
BOXm	NULL
STATm	NULL
BOXd	NULL
hIL-9	NULL
:	NULL
-	NULL
oto	NULL
-	NULL
+0	NULL
-	NULL
o+	NULL
-	NULL
+o	NULL
-	NULL
+	NULL
-	NULL
$	NULL
0	NULL
-	NULL
#	NULL
0	NULL
-	NULL
+	NULL
jun®	NULL
#	NULL
448	NULL
88	NULL
>	NULL
ag	NULL
=~	NULL
rod	NULL
;	NULL
09	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Induction	NULL
of	NULL
early	NULL
response	NULL
gene	NULL
in	NULL
TS1	NULL
transfectants	NULL
expressing	NULL
hIL-9Ra	NULL
.	NULL

Cells	NULL
were	NULL
starved	NULL
in	NULL
serum-free	NULL
medium	NULL
for	NULL
8	NULL
h	NULL
and	NULL
were	NULL
either	NULL
not	NULL
stimulated	NULL
or	NULL
stimulated	NULL
with	NULL
hIL-9	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
1	NULL
h.	NULL
5	NULL
ug	NULL
of	NULL
total	NULL
RNAs	NULL
from	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
were	NULL
prepared	NULL
and	NULL
separated	NULL
through	NULL
a	NULL
1	NULL
%	NULL
formaldehyde-agarose	NULL
gel	NULL
and	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

The	NULL
same	NULL
membrane	NULL
was	NULL
sequentially	NULL
hybridized	NULL
with	NULL
different	NULL
*°P-labeled	NULL
c-Myc	NULL
,	NULL
JunB	NULL
,	NULL
c-Jun	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
eDNA	NULL
probes	NULL
.	NULL

W	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

GAPDH	NULL
sion	NULL
in	NULL
hIL-9R-transfected	NULL
cells	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
primary	NULL
response	NULL
genes	NULL
as	NULL
potentially	NULL
critical	NULL
targets	NULL
for	NULL
cytokine-in-duced	NULL
proliferation	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
(	NULL
40-42	NULL
)	NULL
.	NULL

Although	NULL
our	NULL
previous	NULL
study	NULL
has	NULL
shown	NULL
that	NULL
IL-9	NULL
could	NULL
induce	NULL
activation	NULL
of	NULL
jun	NULL
B	NULL
and	NULL
c-myc	NULL
in	NULL
a	NULL
human	NULL
growth	NULL
factor-depend-ent	NULL
cell	NULL
line	NULL
(	NULL
19	NULL
)	NULL
,	NULL
the	NULL
correlation	NULL
between	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
two	NULL
genes	NULL
and	NULL
IL-9-mediated	NULL
cell	NULL
proliferation	NULL
has	NULL
never	NULL
been	NULL
demonstrated	NULL
.	NULL

Our	NULL
present	NULL
study	NULL
indicated	NULL
that	NULL
activation	NULL
of	NULL
e-mye	NULL
upon	NULL
stimulation	NULL
with	NULL
IL-9	NULL
depends	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
the	NULL
membrane-proximal	NULL
and	NULL
the	NULL
BOX1	NULL
downstream	NULL
regions	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
hIL-9Ra	NULL
,	NULL
suggesting	NULL
that	NULL
IL-9-induced	NULL
expression	NULL
of	NULL
c-mye	NULL
may	NULL
require	NULL
JAK	NULL
kinases	NULL
and	NULL
signals	NULL
associated	NULL
with	NULL
the	NULL
BOX1	NULL
downstream	NULL
region	NULL
.	NULL

This	NULL
is	NULL
different	NULL
from	NULL
IL-2Rf	NULL
,	NULL
in	NULL
which	NULL
the	NULL
serine-rich	NULL
region	NULL
is	NULL
important	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
e-myc	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
conjunction	NULL
with	NULL
the	NULL
functional	NULL
study	NULL
,	NULL
c-myc	NULL
is	NULL
not	NULL
likely	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
IL-9-mediated	NULL
cell	NULL
proliferation	NULL
in	NULL
TS1	NULL
cells	NULL
,	NULL
since	NULL
the	NULL
induction	NULL
of	NULL
c-myc	NULL
by	NULL
IL-9	NULL
was	NULL
greatly	NULL
impaired	NULL
in	NULL
STAT3	NULL
m	NULL
and	NULL
BOXm	NULL
transfectants	NULL
that	NULL
can	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
hIL-9	NULL
.	NULL

Interestingly	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STAT3	NULL
by	NULL
IL-9	NULL
were	NULL
also	NULL
decreased	NULL
in	NULL
both	NULL
STAT3	NULL
m	NULL
and	NULL
BOXm	NULL
transfectants	NULL
,	NULL
suggesting	NULL
that	NULL
STAT3	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
IL-9-mediated	NULL
activation	NULL
of	NULL
c-myc	NULL
.	NULL

hIL-9-induced	NULL
junB	NULL
activation	NULL
appears	NULL
to	NULL
be	NULL
attributed	NULL
to	NULL
both	NULL
regions	NULL
of	NULL
hIL-9Ra	NULL
and	NULL
correlates	NULL
with	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
.	NULL

Although	NULL
STAT3	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
junB	NULL
promoter	NULL
through	NULL
an	NULL
IL-6	NULL
response	NULL
element	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
junB	NULL
by	NULL
IL-9	NULL
was	NULL
not	NULL
significantly	NULL
decreased	NULL
in	NULL
STAT3	NULL
m	NULL
transfectants	NULL
,	NULL
implicating	NULL
that	NULL
additional	NULL
transcription	NULL
factors	NULL
may	NULL
be	NULL
induced	NULL
by	NULL
IL-9	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
junB	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
two	NULL
important	NULL
regions	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
hIL-9Ra	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
IL-9-induced	NULL
cell	NULL
growth	NULL
and	NULL
signal	NULL
transduction	NULL
.	NULL

A	NULL
membrane-proximal	NULL
region	NULL
between	NULL
amino	NULL
acids	NULL
295	NULL
and	NULL
338	NULL
containing	NULL
the	NULL
BOX1	NULL
motif	NULL
is	NULL
absolutely	NULL
essential	NULL
for	NULL
IL-9-induced	NULL
cell	NULL
proliferation	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
kinases	NULL
and	NULL
a	NULL
BOX1l	NULL
downstream	NULL
sequence	NULL
between	NULL
amino	NULL
acids	NULL
338	NULL
and	NULL
422	NULL
including	NULL
a	NULL
YLPQ	NULL
motif	NULL
is	NULL
critical	NULL
for	NULL
IL-9-induced	NULL
cell	NULL
growth	NULL
,	NULL
activation	NULL
of	NULL
STAT3	NULL
,	NULL
and	NULL
up-regulation	NULL
of	NULL
c-mye	NULL
and	NULL
junB	NULL
gene	NULL
expression	NULL
.	NULL

Since	NULL
both	NULL
of	NULL
these	NULL
two	NULL
regions	NULL
are	NULL
important	NULL
for	NULL
optimal	NULL
cellular	NULL
proliferation	NULL
induced	NULL
by	NULL
IL-9	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
reconstitution	NULL
of	NULL
a	NULL
fully	NULL
functional	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
21340	NULL
IL-9	NULL
Receptor	NULL
a	NULL
Domains	NULL
Critical	NULL
for	NULL
Signal	NULL
Transduction	NULL
hIL-9R	NULL
requires	NULL
the	NULL
cooperation	NULL
or	NULL
cross-talk	NULL
between	NULL
different	NULL
signaling	NULL
transducers	NULL
associated	NULL
with	NULL
hIL-9R	NULL
cytoplasmic	NULL
do-main	NULL
,	NULL
even	NULL
though	NULL
activation	NULL
of	NULL
distinctive	NULL
signaling	NULL
molecules	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
individual	NULL
cytoplasmic	NULL
regions	NULL
of	NULL
hIL-9R	NULL
.	NULL

Acknowledgment-We	NULL
thank	NULL
Steve	NULL
Hulbert	NULL
for	NULL
his	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Houssiau	NULL
,	NULL
F.	NULL
,	NULL
Louahed	NULL
,	NULL
J.	NULL
,	NULL
Vink	NULL
,	NULL
A.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Uyttenhove	NULL
,	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Adv	NULL
.	NULL

Immunol	NULL
.	NULL

54	NULL
,	NULL
79-97	NULL
2	NULL
.	NULL

Yang	NULL
,	NULL
Y.-C.	NULL
,	NULL
Ricciardi	NULL
,	NULL
S.	NULL
,	NULL
Ciarletta	NULL
,	NULL
A.	NULL
,	NULL
Calvetti	NULL
,	NULL
J.	NULL
,	NULL
Kelleher	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
1880-1884	NULL
3	NULL
.	NULL

Uyttenhove	NULL
,	NULL
C.	NULL
,	NULL
Simpson	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
6943-6948	NULL
4	NULL
.	NULL

Dugas	NULL
,	NULL
B.	NULL
,	NULL
Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Pene	NULL
,	NULL
J.	NULL
,	NULL
Bonneloy	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Peti-France	NULL
,	NULL
C.	NULL
,	NULL
Braguet	NULL
,	NULL
P.	NULL
,	NULL
Bousguet	NULL
,	NULL
J.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Mencia-Huerta	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
1687-1692	NULL
5	NULL
.	NULL

Hultner	NULL
,	NULL
L.	NULL
,	NULL
Moeller	NULL
,	NULL
J.	NULL
,	NULL
Schimitt	NULL
,	NULL
E.	NULL
,	NULL
Jager	NULL
,	NULL
G.	NULL
,	NULL
Reishbach	NULL
,	NULL
G.	NULL
,	NULL
Ring	NULL
,	NULL
I.	NULL
L.	NULL
,	NULL
and	NULL
Dormer	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
3440-8446	NULL
6	NULL
.	NULL

Eeklund	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Ghildyal	NULL
,	NULL
N.	NULL
,	NULL
Austen	NULL
,	NULL
F.	NULL
K.	NULL
,	NULL
and	NULL
Stevens	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
4266-4278	NULL
7	NULL
.	NULL

Williams	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Anderson	NULL
,	NULL
D.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
Boswell	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Cooper	NULL
,	NULL
S.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
and	NULL
Broxmeyer	NULL
,	NULL
H.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
906-911	NULL
8	NULL
.	NULL

Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
van	NULL
der	NULL
Lugt	NULL
,	NULL
N.	NULL
,	NULL
Vink	NULL
,	NULL
A.	NULL
,	NULL
van	NULL
Roon	NULL
,	NULL
M.	NULL
,	NULL
Godfraind	NULL
,	NULL
C.	NULL
,	NULL
Warnier	NULL
,	NULL
G.	NULL
,	NULL
Merz	NULL
,	NULL
H.	NULL
,	NULL
Feller	NULL
,	NULL
A.	NULL
,	NULL
Berns	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
1327-1332	NULL
9	NULL
.	NULL

Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Vink	NULL
,	NULL
A.	NULL
,	NULL
Louahed	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
1300-1305	NULL
10	NULL
.	NULL

Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Asao	NULL
,	NULL
H.	NULL
,	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Kumaki	NULL
,	NULL
S.	NULL
,	NULL
Tanaka	NULL
,	NULL
N.	NULL
,	NULL
Munataka	NULL
,	NULL
H.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
379-382	NULL
11	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Ziegler	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
,	NULL
Cao	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1877-1880	NULL
12	NULL
.	NULL

Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Andich	NULL
,	NULL
M.	NULL
,	NULL
Eisenman	NULL
,	NULL
J.	NULL
,	NULL
Shanebeck	NULL
,	NULL
K.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
,	NULL
Kumaki	NULL
,	NULL
S.	NULL
,	NULL
Namen	NULL
,	NULL
A.	NULL
,	NULL
Park	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Anderson	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
2822-2830	NULL
13	NULL
.	NULL

Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Kondo	NULL
,	NULL
M.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
115-120	NULL
14	NULL
.	NULL

Renauld	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Druez	NULL
,	NULL
C.	NULL
,	NULL
Kermouni	NULL
,	NULL
A.	NULL
,	NULL
Houssiau	NULL
,	NULL
F.	NULL
,	NULL
Uyttenhove	NULL
,	NULL
C.	NULL
,	NULL
Van	NULL
Roost	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
and	NULL
Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
5690-5694	NULL
15	NULL
.	NULL

Chang	NULL
,	NULL
M.-S.	NULL
,	NULL
Engel	NULL
,	NULL
G.	NULL
,	NULL
Benedict	NULL
,	NULL
C.	NULL
,	NULL
Basu	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
McNinch	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
3199-3205	NULL
16	NULL
.	NULL

Minami	NULL
,	NULL
Y.	NULL
,	NULL
Kono	NULL
,	NULL
T.	NULL
,	NULL
Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11	NULL
,	NULL
245-267	NULL
17	NULL
.	NULL

Yin	NULL
,	NULL
T.	NULL
,	NULL
Yang	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Yang	NULL
,	NULL
Y.-C.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
3101-8106	NULL
18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
.	NULL

Coffer	NULL
,	NULL
P.	NULL
,	NULL
Lutticken	NULL
,	NULL
C.	NULL
,	NULL
van	NULL
Puijenbrock	NULL
,	NULL
A.	NULL
,	NULL
Klop-de	NULL
Jonge	NULL
,	NULL
M.	NULL
,	NULL
Horn	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Yin	NULL
,	NULL
T.	NULL
,	NULL
Keller	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Lienhard	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Yang	NULL
,	NULL
Y.-C.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
20497-20502	NULL
Kang	NULL
,	NULL
L.	NULL
Y.	NULL
,	NULL
and	NULL
Yang	NULL
,	NULL
Y.-C.	NULL
(	NULL
1995	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

163	NULL
,	NULL
623-630	NULL
Vallette	NULL
,	NULL
F.	NULL
,	NULL
Mege	NULL
,	NULL
E.	NULL
,	NULL
Reiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Adesnik	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
728-733	NULL
Yin	NULL
,	NULL
T.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Yang	NULL
Y.-C.	NULL
(	NULL
1994	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

22	NULL
,	NULL
467-472	NULL
Yang	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Yang	NULL
,	NULL
Y.-C.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
2526-2533	NULL
Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
162	NULL
,	NULL
156-159	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Nishio	NULL
,	NULL
Y.	NULL
,	NULL
Inoue	NULL
,	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
X.-J	NULL
.	NULL

,	NULL
Wei	NULL
,	NULL
S.	NULL
,	NULL
Matsusaka	NULL
,	NULL
T.	NULL
,	NULL
Yoshida	NULL
,	NULL
K.	NULL
,	NULL
Sudo	NULL
,	NULL
T.	NULL
,	NULL
Naruto	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
63-71	NULL
Herrea	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Shaw	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
Nordheim	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
840	NULL
,	NULL
68-70	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Mori	NULL
,	NULL
H.	NULL
,	NULL
Doi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
837-845	NULL
Stahl	NULL
,	NULL
N.	NULL
,	NULL
Farruggella	NULL
,	NULL
T.	NULL
,	NULL
Boulton	NULL
,	NULL
T.	NULL
,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Yancopoulos	NULL
,	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1849-1353	NULL
Demoulin	NULL
,	NULL
J.-B	NULL
.	NULL

,	NULL
Uyttenhove	NULL
C.	NULL
,	NULL
Van	NULL
Roost	NULL
,	NULL
E.	NULL
,	NULL
Lestre	NULL
,	NULL
B.	NULL
,	NULL
Donckers	NULL
,	NULL
D.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Renauld	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
4710-4716	NULL
Murakami	NULL
,	NULL
M.	NULL
,	NULL
Narazaki	NULL
,	NULL
M.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Yawata	NULL
,	NULL
H.	NULL
,	NULL
Yasukawa	NULL
,	NULL
H.	NULL
,	NULL
Hamaguchi	NULL
,	NULL
M.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
11849-11353	NULL
Narazaki	NULL
,	NULL
M.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Yoshida	NULL
,	NULL
K.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taga	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
2285-2289	NULL
Miura	NULL
,	NULL
O.	NULL
,	NULL
Cleveland	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Ihle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
1788-1795	NULL
DaSilva	NULL
,	NULL
L.	NULL
,	NULL
Howard	NULL
,	NULL
O.	NULL
M.	NULL
,	NULL
Rui	NULL
,	NULL
H.	NULL
,	NULL
Kirken	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Farrar	NULL
,	NULL
W.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
18267-18270	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Adv	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
,	NULL
1-35	NULL
Kirken	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Rui	NULL
,	NULL
H.	NULL
,	NULL
Malabarba	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Howard	NULL
,	NULL
O.	NULL
M.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Farrar	NULL
,	NULL
W.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Cytokine	NULL
7	NULL
,	NULL
689-700	NULL
Higuchi	NULL
,	NULL
M.	NULL
,	NULL
Asao	NULL
,	NULL
H.	NULL
,	NULL
Tanaka	NULL
,	NULL
N.	NULL
,	NULL
Oda	NULL
,	NULL
K.	NULL
,	NULL
Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26	NULL
,	NULL
1822-1827	NULL
Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Friedmann	NULL
,	NULL
M.	NULL
,	NULL
Berg	NULL
,	NULL
M.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Goldman	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Schmalstieg	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
266	NULL
,	NULL
1042-1045	NULL
Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
Kawahara	NULL
,	NULL
A.	NULL
,	NULL
Fujii	NULL
,	NULL
H.	NULL
,	NULL
Nakagawa	NULL
,	NULL
Y.	NULL
,	NULL
Minami	NULL
,	NULL
Y.	NULL
,	NULL
Liui	NULL
,	NULL
Z.	NULL
J.	NULL
,	NULL
Oishi	NULL
,	NULL
I.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
266	NULL
,	NULL
1045-1047	NULL
Yamanaka	NULL
,	NULL
Y.	NULL
,	NULL
Nakajima	NULL
,	NULL
K.	NULL
,	NULL
Fukada	NULL
,	NULL
T.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hirano	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
1557-1565	NULL
Horie	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Broxmeyer	NULL
,	NULL
H.	NULL
E.	NULL
(	NULL
19983	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
968-973	NULL
Hunter	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
249-260	NULL
Lui	NULL
,	NULL
J.	NULL
,	NULL
Clegg	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
Shoyab	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

8	NULL
,	NULL
807-813	NULL
Kojima	NULL
,	NULL
H.	NULL
,	NULL
Nakajima	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hirano	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Oncogene	NULL
12	NULL
,	NULL
547-554	NULL
Kruijer	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
10	NULL
,	NULL
985-994	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Critical	NULL
Cytoplasmic	NULL
Domains	NULL
of	NULL
Human	NULL
Interleukin-9	NULL
Receptor	NULL
¢	NULL
Chain	NULL
in	NULL
Interleukin-9-mediated	NULL
Cell	NULL
Proliferation	NULL
and	NULL
Signal	NULL
Transduction	NULL
Yuan	NULL
Xiao	NULL
Zhu	NULL
,	NULL
Hui	NULL
Bin	NULL
Sun	NULL
,	NULL
Monica	NULL
Lik-Shing	NULL
Tsang	NULL
,	NULL
Jon	NULL
McMahel	NULL
,	NULL
Susan	NULL
Grigsby	NULL
,	NULL
Tinggui	NULL
Yin	NULL
and	NULL
Yu-Chung	NULL
Yang	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:21334-21340.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.34.21334	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/34/21334	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
44	NULL
references	NULL
,	NULL
21	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
334.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

